China Medical University

China Medical University Hospital's Breakthrough Drug of 'Allogenic mRNA CAR-T' & Its GenAI 'gHi' Standing Out in Healthcare+ Expo (Taiwan) 2023

Retrieved on: 
Thursday, December 28, 2023
GHI, Dicarboxylic acid, Roger Hawkins (drummer), Attention, Neoplasm, Multimedia, U.S. FDA, Allogenic succession, Messenger, FDA, Lung, Breast, Mortality, Medical school, Regenerative medicine, PCR, News, Cancer, AI, Intelligence, China Medical University, Artificial intelligence, Obesity, Hospital, Geography of Taiwan, Formosa Television, Patient, Global health, Safety, Superintendent, Health, Sepsis, Vaccine

Among them, China Medical University Hospital (CMUH, Taiwan) was attracted most attention in the exposition.

Key Points: 
  • Among them, China Medical University Hospital (CMUH, Taiwan) was attracted most attention in the exposition.
  • Those items of the cutting-edge products received great attention at the Healthcare+ Expo (Taiwan) 2023.
  • In the news video of Formosa TV, Taiwan's broadcast news station, China Medical University and its Healthcare System recently showcased some of its latest innovations and tech at 2023 Healthcare+ Expo Taiwan.
  • Through the Healthcare+ Expo (Taiwan) 2023, the CMUH hopes to enhance the world's premiere medical technology innovation that has been driving improvements in global health.

China Medical University Won 22 National Awards For Smart Healthcare Innovation In 2022 Taiwan Healthcare Expo.

Retrieved on: 
Saturday, December 31, 2022
Ambulance, Exhibition, Patient, Formosa Television, Taipei Nangang Exhibition Center metro station, AI, Bluetooth, China Medical University, Medicine, Sepsis, News, Biotechnology, Regenerative medicine, Multimedia, Geography of Taiwan, Medical school, Invention, Myocardial infarction, New Southbound Policy, Policy, Artificial intelligence, Superintendent, Drug resistance, Bacteria, Research, Hospital, Pharmaceutical industry

TAICHUNG,Taiwan, Dec. 31, 2022 /PRNewswire/ -- In the 2022 Healthcare+ Expo, one of the largest international healthcare fairs in Taiwan, was being held at the Nangang Exhibition Center in December. Of note was the exhibition from Taichung's China Medical University and its related healthcare system. It showed off innovations reflecting six major themes including artificial intelligence and smart medical care. Overall, the university has won 22 national awards for innovation, the highest number in Taiwan. Among them is a big data platform that utilizes environmental and clinical data from over 3 million people, and a smart anti-germ platform that can effectively combat super viruses in hospitals and also save patients from septicemia. So far, it has served more than 100,000 people. Cho Der-yang, Superintendent of China Medical University," It can take as little as one hour to know what kind of bacteria it is, and then whether there is any drug resistance, and then offer assistance in determining which medicine is most appropriate to use." The university will promote its findings and inventions in the 18 nations that are part of the government's New Southbound Policy so that the world can see Taiwan's innovative capabilities. The university will promote its findings and inventions in the 18 nations that are part of the government's New Southbound Policy so that the world can see Taiwan's innovative capabilities.

Key Points: 
  • Of note was the exhibition from Taichung's China Medical University and its related healthcare system.
  • Overall, the university has won 22 national awards for innovation, the highest number in Taiwan.
  • This year in 2022, China Medical University focused on six themes, including AI, smart medical care and regenerative medicine.
  • The university has won 22 national awards for innovation, the highest number ever.

Nanoscope Therapeutics Expands Clinical and CMC Leadership Team with Gene Therapy Pharma Experience

Retrieved on: 
Monday, November 7, 2022
Transfer, Company, VP, CGMP, Fast track (FDA), FDA, Adverum Biotechnologies, Head, RP, Novartis, Therapy, University, Health technology, Medical school, Wayne State University, CEO, CNS, China Medical University, Diosynth, Hematology, Retina, CMC, University of Texas Southwestern Medical Center, Ophthalmology, Retinitis pigmentosa, Cardiorenal syndrome, Geographic atrophy, Patient, Pharmaceutical industry, Biotechnology, Immunology, Atomic de Broglie microscope, Chemistry, Stargardt disease

"We are excited to welcome Jean and Victor, both experienced biopharmaceutical leaders in gene therapy, to the Nanoscope team, and we look forward to the integral roles they will play in bolstering our clinical and CMC capabilities," saidSulagna Bhattacharya, CEO of Nanoscope.

Key Points: 
  • "We are excited to welcome Jean and Victor, both experienced biopharmaceutical leaders in gene therapy, to the Nanoscope team, and we look forward to the integral roles they will play in bolstering our clinical and CMC capabilities," saidSulagna Bhattacharya, CEO of Nanoscope.
  • Ms. Chang brings more than 20 years of experience in clinical operations and project management resulting in successful clinical trials in various therapeutic areas including CNS, cardiorenal, hematology, oncology, and ophthalmology.
  • Previously, she served as Executive Director of Clinical Operations at Catalyst Biosciences, and Senior Director, Clinical Operations at Adverum Biotechnologies.
  • Mr. Adeniyi has a decade of experience in cGMP manufacturing of biologics, including cell and gene therapy, leading successful manufacturing of clinical trial materials.

Inspired to Inspire by her personal life experience, knowledge and desire to Look Lavish, Youthful and Beautiful, Dr. Suzanne Yu announces she is creating a new High Fashion Clothing Brand and Beauty line for Anti Aging

Retrieved on: 
Friday, April 22, 2022
Protein, Clothing, Habit, Sleep, Businessperson, Woman, University of Wisconsin–Madison, COVID-19, Vitamin C, Life, The Comeback Trail, Government, Freedom, Mental, Doctor of Philosophy, China Medical University, Education, Goal, Exercise, The Hardships of the English Laws in Relation to Wives, Revolution, Social media, Heart, Beauty, Student, Trauma, Love, China Medical University (PRC), Foundation, Yoga, Interview, Singing, Fasting, New York University Grossman School of Medicine, Medical school, SPF, Dance, Name, Industry, Fats, Multimedia, Child, Magazine cover indicator, Carbohydrate, University, Comeback, Time, Nature, Medicine, Entertainment, Beauty salon

Suzanne is a Doctor, Philanthropist, Movie Producer, Actress, Business Woman, and is going to be launching her own High Fashion Brand and Skincare line for anti aging.

Key Points: 
  • Suzanne is a Doctor, Philanthropist, Movie Producer, Actress, Business Woman, and is going to be launching her own High Fashion Brand and Skincare line for anti aging.
  • Suzanne knows how important it is to take care of herself with healthy habits most important how you present yourself to others through clothing and beauty.
  • Suzanne was born in ShenYang, China but immigrated to the US for better opportunities and freedom.
  • Suzanne recalls dark memories from her childhood in China that became the trigger for her desire for change.

Moleculin Announces Appointment of Joy Yan, M.D., Ph.D. to Board of Directors

Retrieved on: 
Tuesday, March 1, 2022
Board of directors, Strategic planning, Johns Hopkins University, China Medical University, Risk, Twitter, Virus, Growth, Board, Securities Exchange Act of 1934, STS, Medical school, Security (finance), University, University of Washington, Neoplasm, COVID-19, AML, Control, Company, Moa, T-cell lymphoma, Private Securities Litigation Reform Act, Brain, Nivolumab, Tetanic contraction, U.S. Securities and Exchange Commission, BMS, Cancer, Bristol Myers Squibb, Acute myeloid leukemia, LinkedIn, Terminology, Science, Leadership, Ipilimumab, Molecular biology, Coronavirus Scientific Advisory Board (Turkey), Independent Board for Presbyterian Foreign Missions, Securities Act of 1933, Antimetabolite, Janssen, Form 10-K, IPO, TKI, CEO, Doctor of Philosophy, RTOR, SEC, Pharmaceutical industry, Management, Biochemistry, Facebook, Bayer, Director

"We are incredibly pleased to welcome Dr. Yan to our Board of Directors.

Key Points: 
  • "We are incredibly pleased to welcome Dr. Yan to our Board of Directors.
  • Dr. Yan added, "I am excited to join the Moleculin Board of Directors and provide guidance to help position the Company for continued growth.
  • I believe that Moleculin's pipeline and science will propel the Company to its next development phase and build value for stakeholders."
  • Joy Yan, M.D., Ph.D., currently serves as an Independent Board Director at Checkmate Pharmaceuticals.

Checkmate Pharmaceuticals Strengthens Board of Directors with Appointment of Joy Yan, M.D., Ph.D.

Retrieved on: 
Monday, December 20, 2021
Control, Melanoma, Board, Nilesh, Securities Act of 1933, NASDAQ, Review, TKI, Nivolumab, Tetanic contraction, TLR9, Analysis, RTOR, Forward-looking statement, Medical school, LinkedIn, RNA, University of Washington Department of Bioengineering, Financial condition report, U.S. Securities and Exchange Commission, Social media, Janssen Pharmaceuticals, Doctor of Philosophy, Security (finance), GLOBE, Interim, Molecular biology, Moa, Â, Board of directors, Financial compensation, Bayer, COVID-19, DNA, Strategic planning, Bristol Myers Squibb, Twitter, II, Result, China Medical University, CpG, Private Securities Litigation Reform Act, III, Annual report, Johns Hopkins University, File, Immune system, University, Ipilimumab, Pharmaceutical industry, Vaccine, Checkmate, Biochemistry

We are pleased to welcome Joy to Checkmates Board.

Key Points: 
  • We are pleased to welcome Joy to Checkmates Board.
  • On behalf of the entire Board, I thank Nilesh for his contributions to Checkmate.
  • Checkmate Pharmaceuticals is a clinical stage biotechnology company focused on developing its proprietary technology to harness the power of the immune system to combat cancer.
  • The information that Checkmate Pharmaceuticals posts on these channels and websites could be deemed to be material information.